Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient

American Journal of the Medical Sciences

Volumn 337, Issue 4, 2009, Pages 300-301

  Czosnowski, Lauren M ^a   Hudson, Joanna Q ^b   Canada, Robert B ^b  

^a METHODIST UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Bisphosphonates; Dialysis; Hypercalcemia; Hyperparathyroidism; Pamidronate

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; CINACALCET; CITALOPRAM; INSULIN; LACTULOSE; METOPROLOL; NOVOLIN 70/30; OXYCODONE PLUS PARACETAMOL; PAMIDRONIC ACID; PARATHYROID HORMONE; SEVELAMER; UNCLASSIFIED DRUG; BISPHOSPHONIC ACID DERIVATIVE;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; HEMODIALYSIS PATIENT; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; MALE; PARATHYROID HORMONE BLOOD LEVEL; SINGLE DRUG DOSE; TREATMENT FAILURE; TREATMENT RESPONSE; BLOOD; CHRONIC KIDNEY FAILURE; RENAL REPLACEMENT THERAPY;

AGED; CALCIUM; DIPHOSPHONATES; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY FAILURE, CHRONIC; MALE; RENAL DIALYSIS;

EID: 65549085314     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e31818a84a5     Document Type: Article

References (8)

1. Potts JT. Diseases of the parathyroid gland and other hyper- and hypocalcemic disorders. In: Kasper D, Braunwald E, Fauci A, editors. Harrison's principles of internal medicine, 16th ed. New York (NY): McGraw-Hill; 2005. p. 2249-2267
2. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(suppl 3):S1-S201.
3. Sensipar package insert. Thousand Oaks, CA: Amgen; 2008.
4. Strippoli GF, Palmer S, Tong A, et al. Meta-analysis of biochemical and patient-level effects of calcimimetic therapy. Am J Kidney Dis 2006;47:715-726
5. Aredia package insert. East Hanover, NJ: Novartis; 2007.
6. Torregrosa JV, Moreno A, Mas M, et al. Usefulness of pamidronate in severe secondary hyperparathyroidism in patients undergoing hemodialysis. Kidney Int 2003;63:S88-S90. (Pubitemid 36605871)
7. Trimarchi H, Lombi F, Forrester M, et al. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient. Nat Clin Pract Nephrol 2006;2:459-463 (Pubitemid 44174537)
8. Davenport A, Goel S, Mackenzie JC. Treatment of hypercalcemia with pamidronate in patients with end stage renal failure. Scand J Urol Nephrol 1993;27:447-541. (Pubitemid 24005446)